Rheumatoid Arthritis

  • Rheumatoid arthritis is an autoimmune disease common in middle age, especially in women. The disease affects peripheral joints, including the wrists, feet, ankles, and knees. The cause is unknown and eyes and skin also can be involved. Early aggressive therapy with immunosuppressive drugs and anti-inflammatories appears to delay joint destruction. More recently, biologic agents have been added to regimens that include TNF inhibitors, WBC modulators, and growth factor inhibitors. Research is ongoing to evaluate the effects of stem cells on auto-immune conditions. According to the Journal of Translational Research, “The ability of MSC to inhibit immune response, while offering the possibility of inducing/accelerating healing of tissue that has already been damaged, makes this population attractive for treatment of autoimmune disorders.” Read more. We have been investigating deployment of SVF to local “hot spots” combined with intravenous infusion.  Data is available showing reasonably good responses in a majority of patients.  Positive data is still not a guarantee that you would respond in that manner but gives you an idea of what we have found based upon the patient’s own responses. As data accumulation can change with increasing numbers (as well as degrees of injury) you should consult with our team for the latest data. 

Why Personal Cell Therapy With Adipose-Derived Stem Cells for RA?

Personal cell therapy with adipose-derived stem cells represents an ideal way of repairing injuries and medical conditions.  Our bodies are made of cells and every injury or medical condition represents some kind of cell damage.  If we can repair or replace our injured or ailing cells with functional cells, then we can restore normal function and/or reduce pain and dysfunction that results.  

Stem cells are uniquely capable of repairing or replacing damaged cells but their ability to do that really depends on two things – a) the state of the condition or injury and b) the presence of adequate numbers and functioning stem cells.  Since we can generally obtain a very high number of functioning cells from your own adipose tissue and even grow your own cells in a laboratory environment, we should be able to provide adequate numbers of cells.  The state of your injury is something that can’t always know – sometimes we can imply that your injury will be responsive to cell therapy based upon how it responded to other therapies (e.g. steroids), but without visualizing or having pathology samples we must infer or simply treat the condition to ascertain its ability to respond.  We know from a variety of studies that the sooner you treat a problem, the easier it is to predict a satisfactory result.  Also, some conditions require drug or surgical intervention to optimize their ability to be repaired.  If there is an infection, it needs to be treated before you can repair the damage.  If there’s a fracture it needs to be stabilized before you can help it repair.  If there’s scar tissue, then it may need to be removed before you can restore normal tissue function.  

Since beginning investigative treatments in 2010 we have acquired extensive clinical data and seen our treatment results recapitulated by hundreds of other physicians.  As such, we do not consider these interventions “experimental” but rather “investigative” as we accumulate more data to help us advance personal cell therapy as an important, if not essential arm of medical and surgical procedures.  It is important to understand that these are your own cells, and not subject to FDA oversight,  as they are isolated for your own personal use during the same-day surgical procedure.  We can do double-blind studies but our current data speaks for itself.   Tens of thousands of patients have tried numerous interventions prior to stem cell therapy –  without improvement,  so when they improve following delivery of their own SVF cells, it’s highly unlikely that this is a placebo effect. 

After a decade of research, we have developed a specific SVF deployment protocol that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Schedule your FREE Consultation

Do you have additional questions on how stem cells work and how they relate to your condition?  Contact us today to schedule your FREE, no-obligation consultation. To get the process started, simply fill out our short Confidential Candidate Application.  Once we receive your application, a stem cell coordinator will call you to schedule your complimentary phone or in-person consultation. We look forward to educating you on the latest research for stem cell therapy.